Pharmaceutical industry leaders in Nigeria have said the country is not yet serious about achieving medicine security, pointing to heavy import dependence, foreign exchange volatility, high operating costs, weak supply chain coordination and low patronage of locally made products. This Nigeria medicine security warning highlights structural vulnerabilities in the domestic health supply chain that ultimately impact patient access.
Regulatory Enforcement and the Nigeria Medicine Security Warning
Margaret Ilomuanya, a professor at the Faculty of Pharmacy, University of Lagos, said: “Well, the first thing is, I think, as a nation, we are not serious about achieving medicine security.” She argued that the gap is in enforcement rather than legislation, adding: “We do not need more laws. We need to work with the ones that we already have.”
Leadership Priorities and Market Challenges
Lolu Ojo, managing director and chief executive of Merit Healthcare Limited, said what the sector needs is “leadership that is intentional about achieving medicine” security. Chijioke Onyia, managing director of Pinecrest Healthcare Limited, urged the government to demonstrate political will. Addressing the Nigeria medicine security warning requires coordinated effort from both regulators and policymakers to incentivize domestic production.
Unused Capacity and the Economic Toll
Pharmanews reported that significant installed local manufacturing capacity remains unused despite continued reliance on imports, and that one speaker cited borrowing costs as high as 36 per cent for businesses.
Supply Chain Economics and Healthcare Impact
Idle local capacity alongside import dependence means Nigeria is paying twice, in foreign exchange and in unused factory investment. Taking the Nigeria medicine security warning seriously is essential to reversing this economic drain and ensuring reliable access to essential therapies.
Frequently Asked Questions
Why is local pharmaceutical manufacturing capacity unused in Nigeria?
Local manufacturers face severe economic headwinds, including borrowing costs as high as 36 per cent, foreign exchange volatility affecting raw material purchases, and a lack of robust patronage for locally made pharmaceutical products.
What do experts suggest to improve medicine security?
Experts emphasize that Nigeria does not need new legislation, but rather stronger enforcement of existing laws and intentional, politically backed leadership to support domestic drug production and streamline the supply chain.
Drug Pricing in Africa: The Hidden Healthcare Crisis Access to affordable medicines is a cornerstone of public health. Yet across Africa, millions of people struggle to buy even the most basic drugs. According to the World Health Organization (WHO), up to 50% of…
Nigeria Prize for Science Awarded to Pioneer of… In a groundbreaking achievement, the Advisory Board of The Nigeria Prize for Science, convened in Lagos, declared Professor Hippolite Amadi the winner of the prestigious 2023 edition for his pioneering work in respiratory technologies aimed…
Health sector underrepresented on Nigerian Stock Exchange Lagos, Nigeria – The Nigerian healthcare sector, a critical driver of national development, remains strikingly underrepresented on the Nigerian Stock Exchange (NGX), despite increasing demand for medical services, rising health technology adoption, and the growing…
African Mills Turn Local Cotton Into Medical… NAIROBI, KENYA — Manufacturers across the continent are accelerating African medical textile manufacturing by processing locally grown cotton into essential clinical supplies like medical gauze, bandages, and surgical drapes rather than exporting raw fiber overseas.…
